Searched for
CHEMOTHERAPY DRUGS
Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
- Top private hospitals may drop out of government health plansPrivate hospitals in India are feeling the pinch as government health schemes yield diminishing returns. This downturn provokes a critical ...
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- US Stocks: Corcept Therapeutics shares surge 32% as lead drug gets FDA nod for ovarian cancerCorcept Therapeutics shares surged after the FDA approved its drug, Lifyorli, for a tough ovarian cancer. This new therapy, combined with c...
- Miracle drug kills cancer 20,000x faster, and scientists say it has zero side effectsResearchers have redesigned a common chemotherapy drug into a spherical nucleic acid (SNA), dramatically increasing its potency by 20,000 t...
- Regulator asks state bodies to limit scope of key cancer drugIndia's drug regulatory authority has instructed state-level counterparts to mandate manufacturers of Olaparib tablets in 100 mg and 150 mg...
- Cancer treatment without Chemotherapy? Here is how it could be possibleChemotherapy for decades was considered “the rule, the dogma,” for treating cancer, but various data offer some confirmation that the metho...
- New 3D device may cut side-effects of chemotherapy including hair loss, nausea & heart failureThe device absorbs excess chemotherapy drugs before they spread throughout the body.
- Zydus Cadila gets USFDA nod for chemotherapy drugThe company has received final approval from the US Food and Drug Administration (USFDA) to market the drug, Zydus Cadila said in a regulat...
- Implanted ports for improving life of cancer patientsWith the technology of implanted ports aimed at increasing the ease of patients fast developing, such ports are being seen to minimise impa...
- Indian woman sentenced to 20 years for healthcare fraudMeera Sachdeva was sentenced to 20 years in federal prison on charges that she defrauded Medicare by submitting false claims for chemothera...
- Dabur gets approval for chemotherapy agentDabur Pharma says it has received a final approval from the US Food and Drug Administration for its chemotherapy drug Epirubicin injection.
Load More
